Repositioning of Itraconazole for the Management of Ocular Neovascularization Through Surface-Modified Nanostructured Lipid Carriers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repositioning of Itraconazole for the Management of Ocular Neovascularization Through Surface-Modified Nanostructured Lipid Carriers

Published:2019-06 Issue:4 Volume:17 Page:178-190
ISSN:1540-658X
Container-title:ASSAY and Drug Development Technologies
language:en
Short-container-title:ASSAY and Drug Development Technologies

Author:

Selvaraj Kousalya¹,Kuppusamy Gowthamarajan¹,Krishnamurthy Jayashree²,Mahalingam Ravichandran³,Singh Sachin Kumar⁴,Gulati Monica⁴

Affiliation:

1. Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research (Deemed to be University), Ootacamund, India.

2. Department of Pathology, JSS Medical College, JSS Academy of Higher Education and Research (Deemed to be University), Mysuru, India.

3. Citragen Pharmaceuticals, Inc., San Francisco, California.

4. School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/adt.2018.898

Reference31 articles.

1. Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats

2. Ocular Complications After Anti–Vascular Endothelial Growth Factor Therapy in Medicare Patients With Age-Related Macular Degeneration

3. Complications in patients after intravitreal injection of bevacizumab

4. Current nanotechnology approaches for the treatment and management of diabetic retinopathy

5. Inhibition of Angiogenesis by the Antifungal Drug Itraconazole

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravitreal therapeutic nanoparticles for age-related macular degeneration: Design principles, progress and opportunities;Advances in Colloid and Interface Science;2024-07

2. Improvement of Bioavailability of Bilastine Nanostructured Lipid Carriers for the Treatment of Allergic Rhinitis;BioNanoScience;2024-06-28

3. Current Insights into Targeting Strategies for the Effective Therapy of Diseases of the Posterior Eye Segment;Critical Reviews™ in Therapeutic Drug Carrier Systems;2024

4. Recent Updates on Nanocarriers for Drug Delivery in Posterior Segment Diseases with Emphasis on Diabetic Retinopathy;Current Diabetes Reviews;2023-10-17

5. Nanostructured Lipid Carriers Mediated Drug Delivery to Posterior Segment of Eye and their In-vivo Successes;Current Pharmaceutical Biotechnology;2023-09-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3